Substance Use Disorder
  • Article
  • Aug 26 2019

The University of Kentucky College of Pharmacy will host its tenth annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m. – 5:30 p.m. on Tuesday, Nov. 12, 2019, in room 124 of the Lee T. Todd, Jr. Building.

  • Article
  • Aug 2 2019

Dr. Michelle Lofwall, UK College of Medicine, is one of three national addiction physician experts who led a team of healthcare professionals in developing a new core curriculum designed to educate primary care providers on the prevention, assessment and treatment of substance use disorders (SUD) throughout the continuum of care.

  • Article
  • Jul 29 2019

The University of Kentucky has launched a new website for information, news-related updates and excerpts regarding their recently awarded $87 million HEALing Communities Study cooperative agreement.

  • Article
  • Jul 23 2019

Few regions have been hit harder by the drug epidemic than Kentucky and need increased access to evidence-based treatment for substance use disorders. The University of Kentucky Department of Psychiatry saw that need and developed a new clinic to better support patients.

  • Article
  • Jul 11 2019

Faculty from the Dept of Psychology in the College of Arts & Sciences and Behavioral Science in the College of Medicine have received two, five-year Research Project Grants from the NIH to study neurobehavioral processes involved in drug use disorders.

  • Video
  • Jun 26 2019

As a busy trauma surgeon, Dr. Phillip Chang saw his fair share of patients who were dealing with significant pain. As per the standards then, these patients would receive opioids for pain management. Most recovered and were weaned off the medication as planned.

  • Article
  • Jun 21 2019

America’s Essential Hospitals, a national trade association, has recognized UK HealthCare for its work to develop safer opioid usage practices within an academic health system.

  • Article
  • May 16 2019

Jennifer Havens has spent the past decade studying the transmission of infectious disease and advocating for the expansion of harm reduction programs. That work entails understanding the link between two health burdens facing the nation, the opioid crisis and cancer.

  • Article
  • May 13 2019

In 2017, Dr. Linda Dwoskin applied to NIDA's Grand Opportunity for Medications Development program for support to continue her quest to develop the first-ever medication to reduce craving and relapse in methamphetamine use disorder.

  • Article
  • May 3 2019

In results University of Kentucky researchers are calling “alarming,” more than three out of 10 undergraduates reported using e-cigarettes, according to a new study published in the March 26 edition of the Journal of American College Health.